New Tools for Drug Discovery & Development

10 - 10:15 a.m. | Introductory Comments

• Bob Wilhelm, Vice Chancellor for Research & Economic Development, UNL
• Jennifer Larsen, Vice Chancellor for Research, UNMC
• Mark Button, Dean, College of Arts & Sciences, UNL
• Ken Bayles, ND3P Co-Lead
• David Berkowitz, ND3P Co-Lead

10:15 - 11:20 a.m. | Plenary 1 with Q&A
Moderators: Don Ronning, UNMC, and Limei Zhang, UNL

11:20 - 11:30 a.m. | Break

11:30 a.m. - 12:30 p.m. | Plenary 2 with Q&A
Moderators: Liangcheng Du, UNL, and Gus Wang, UNMC

12:30 - 1:30 p.m. | Break

1:30 - 2:15 p.m. | Industry / Start-Up Support

2:15  - 3 p.m. | Lightning Talks
with Becky Deegan, UNMC, and Lynnette Carey, AFRRI

3 - 4 p.m. | UNL Featured Scientist with Q&A
Moderators: Ed Harris, UNL, and Aaron Mohs, UNMC

David Baker, PhD

"RosettaFold Opens Up New Vistas for Protein Structure Prediction and Protein Therapeutics Design"
Head of the Institute for Protein Design
University of Washington | Seattle, WA
Baker Lab

Lisa Marcaurelle, PhD

"DNA-Encoded Libraries as a Powerful Tool in Drug Discovery"
Senior Scientific Director
GlaxoSmithKline | Cambridge, MA
LinkedIn Profile

Brad Hunsley, Streck, La Vista
Chris Connelly, Streck, La Vista
Peggy Ruhn, Celerion, Lincoln
Ben Kuspa, Nebraska State Department of Economic Development

David Hage, PhD

"Advancing Drug Development and Characterization through Innovative Uses of Immunoaffinity Chromatography"

James Hewett University Professor of Chemistry
University of Nebraska–Lincoln | Lincoln, NE
Hage Research Group

Drug Discovery — Novel Approaches and Emerging Discoveries

10 - 11 a.m. | Plenary 3
Moderators: Alex Vecchio (UNL) and Corey Hopkins (UNMC)

11 - 11:10 a.m. | Break

11:10 a.m. - 12 p.m. | Emerging Early Career Scientist
Moderators: Nicole Buan, UNL, and Caroline Ng, UNMC

12 - 1 p.m. | Break

1 - 1:45 p.m. | Lightning Talks
with Kate Hyde, UNMC, and James Checco, UNL

1:45 - 2 p.m. | Break

2 - 3 p.m. | UNMC Featured Scientist with Q&A
Moderators: Andrew Dudley (UNMC) and Jiantao Guo (UNL)

3 - 3:45 p.m. | Compound/Invention Disclosure, Marketing and Protection in the Drug Development Enterprise

3:45 - 4 p.m. | Break

4 - 4:30 p.m. | Opportunities & Future Directions

Ken Bayles, ND3P Co-Lead
David Berkowitz, ND3P Co-Lead

Bryan Roth, MD, PhD

"Structure-Guided Discovery of New Ligands for G-Protein-Coupled Receptors (GPCRs)"

Michael Hooker Distinguished Professor
Department of Pharmacology
The University of North Carolina | Chapel Hill, NC
Roth Lab Research

Stephanie Berger, PhD

"High-Affinity Miniprotein Inhibitors for IL-23R and IL-17A and F for Therapy for Autoimmune Diseases"

Senior Research Associate
Institute for Protein Design
University of Washington | Seattle, WA
LinkedIn Profile

R. Lee Mosley, PhD

"Transformative Immunity"

Professor and Director of the Movement Disorders Program in the Center for Neurodegenerative Disorders and the Department of Pharmacology and Experimental Neuroscience
University of Nebraska Medical Center | Omaha, Neb.
Bio

Gyantri Varma, Ph.D., Senior Director of Transactions, Oncology, Business Development & Licensing at AstraZeneca

Arpi Siyahian, Ph.D., Senior Technology Manager at NUtech Ventures